187
Views
8
CrossRef citations to date
0
Altmetric
Articles

Functionalization of bioactive substrates with a F5SCH = CH moiety

, , , , &
Pages 29-43 | Received 05 Jul 2019, Accepted 28 Aug 2019, Published online: 14 Sep 2019

References

  • Welch JT. Fluorine in pharmaceutical and medicinal chemistry: from biophysical aspects to clinical applications. Gouverneur V, Mueller K, editors. London: Imperial College Press; 2012.
  • Wang J, Snachez-Rosello M, Acena JL, et al. Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001–2011). Chem Rev. 2014;114:2432–2506. doi: 10.1021/cr4002879
  • Liang T, Neumann CN, Ritter T. Introduction of fluorine and fluorine-containing functional groups. Angew Chem Int Ed. 2013;52:8214–8264. doi: 10.1002/anie.201206566
  • Kisch P. Modern fluoroorganic chemistry. Weinheim (Germany): Wiley-VCH; 2004.
  • Saethre LJ, Berrah N, Bozek JD, et al. Chemical insights from high-resolution X-ray photoelectron spectroscopy and ab initio theory: propyne, trifluoropropyne, and ethynylsulfur pentafluoride. J Am Chem Soc. 2001;123:10729–10737. doi: 10.1021/ja016395j
  • Kirsch P, Bremer M, Heckmeier M, et al. Liquid crystals based on hypervalent sulfur fluorides: pentafluorosulfuranyl as polar terminal group. Angew Chem Int Ed. 1999;38:1989–1992. doi:10.1002/(SICI)1521-3773(19990712)38:13/14<1989::AID-ANIE1989>3.0.CO;2-K
  • Yang Y-D, Tokunaga E, Akiyama H, et al. Bis(pentafluorosulfanyl)phenyl azide as an expeditious tool for click chemistry toward antitumor pharmaceuticals. ChemMedChem. 2014;9:913–917. doi: 10.1002/cmdc.201400059
  • Altomonte S, Zanda M. Synthetic chemistry and biological activity of pentafluorosulphanyl (SF5) organic molecules. J Fluor Chem. 2012;143:57–93. doi: 10.1016/j.jfluchem.2012.06.030
  • Lentz D, Seppelt K. Chemistry of hypervalent compounds. Akiba K, editor. New York: Wiley-VCH; 1998.
  • Winter RW, Dodean RA, Gard GL. Fluorine containing synthons, ACS symposium series. Vol. 911 Soloshonok VA, editor. Washington, DC: American Chemical Society; 2005.
  • Savoie PR, Welch JT. Preparation and utility of organic pentafluorosulfanyl-containing compounds. Chem Rev. 2015;115:1130–1190. doi: 10.1021/cr500336u
  • Umemoto T, Garrick LM, Saito N. Discovery of practical production processes for arylsulfur pentafluorides and their higher homologues, bis- and tris(sulfur pentafluorides): beginning of a new era of “super-trifluoromethyl” arene chemistry and its industry. Beilstein J Org Chem. 2012;8:461–471. doi: 10.3762/bjoc.8.53
  • Welch JT, Lim DS. Synthesis of pentafluorosulfanyl (SF5) containing aromatic amino acids. Bioorg Med Chem. 2007;15:6659–6666. doi:10.1016/j.jfluchem.2018.06.006 doi: 10.1016/j.bmc.2007.08.012
  • Lim DS, Chou JS, Pak CS, et al. Synthesis and herbicidal activity of a pentafluorosulfanyl analog of trifluralin. Pestic Sci. 2007;32:255–259. doi: 10.1584/jpestics.G06-50
  • Mo T, Mi X, Milner EE, et al. Synthesis of an 8-pentafluorosulfanyl analog of the antimalarial agent mefloquine. Tetrahedron Lett. 2010;51:5137–5140. doi: 10.1016/j.tetlet.2010.07.113
  • Stump B, Eberie C, Schweizer WB, et al. Pentafluorosulfanyl as a novel building block for enzyme inhibitors: trypanothione reductase inhibition and antiprotozoal activities of diarylamines. ChemBioChem. 2009;10:79–83. doi: 10.1002/cbic.200800565
  • Altomonte S, Baillie GL, Ross RA, et al. The pentafluorosulfanyl group in cannabinoid receptor ligands: synthesis and comparison with trifluoromethyl and tert-butyl analogues. RSC Adv. 2014;4:20164–20176. doi: 10.1039/C4RA01212G
  • Falkowska E, Laurent MY, Tognetti V, et al. Synthesis of SF5-substituted isoxazolidines using 1,3-dipolar cycloaddition reactions of nitrones with pentafluorosulfanyl acrylic esters and amides. Tetrahedron. 2015;71:8067–8076. doi: 10.1016/j.tet.2015.08.050
  • Dolbier WR, Aït-Mohand S, Schertz TD, et al. A convenient and efficient method for incorporation of pentafluorosulfanyl (SF5) substituents into aliphatic compounds. J Fluor Chem. 2006;127:1302–1310. doi: 10.1016/j.jfluchem.2006.05.003
  • Ngo SC, Lin J-H, Savoie PR, et al. Preparation and reactions of aliphatic 2-pentafluorosulfanyl aldehydes. Eur J Org Chem. 2012;26:4902–4905. doi: 10.1002/ejoc.201200763
  • Matsnev AV, Qing S-Y, Stanton MA, et al. Pentafluorosulfanyldifluoroacetic acid: rebirth of a promising building block. Org Lett. 2014;16:2402–2405. doi: 10.1021/ol500766v
  • Makarov MV, Rybalkina EY, Anikina LV, et al. 1,5-Diaryl-3-oxo-1,4-pentadienes based on (4-oxopiperidin-1-yl)(aryl)methyl phosphonate scaffold: synthesis and antitumor properties. Med Chem Res. 2017;26:140–152. doi: 10.1007/s00044-016-1726-4
  • Artyushin OI, Vinogradova NM, Sharova EV, et al. Novel approach to the design of potential bioactive alkaloid anabasine conjugates using click chemistry methodology. Heteroatom Chem. 27;2016:245–252. doi: 10.1002/hc.21322
  • Brel VK. Reaction of cytisine with alka-1,3- and -2,3-dien-2-ylphosphonates. Russ J Org Chem. 2016;52:61–68. doi:10.1134/S1070428016120162 doi: 10.1134/S1070428016010127
  • Brel VK. Synthesis and epoxidation of 1,3-, 1,4-, 1,5-alkadienes with pentafluorosulfanyl (SF5) groupings. Synthesis. 2005:1245–1250. doi: 10.1055/s-2005-861859
  • Kusayanagi T, Tsukuda S, Shimura S, et al. The antitumor agent doxorubicin binds to fanconi anemia group F protein. Bioorg Med Chem. 2012;20:6248–6255. doi: 10.1016/j.bmc.2012.09.015
  • Martinez H, Zheng Z, Dolbier WR. Energetic materials containing fluorine. Design, synthesis and testing of furazan-containing energetic materials bearing a pentafluorosulfanyl group. J Fluor Chem. 2012;143:112–122. doi: 10.1016/j.jfluchem.2012.03.010
  • Brel VK. Synthesis of new pentafluorosulfanyl-acrylates (F5SCH=CHCHO, F5SCH=CHCN, F5SCH=CHCOOCH3) and use them as dienophiles in diels-alder reaction. J Fluor Chem. 2007;128:862–867. doi: 10.1016/j.jfluchem.2007.04.013
  • Trushkov IV, Brel VK. Unusual reactivity of 3-chloro-1-pentafluorosulfanylpropene in nucleophilic substitution reactions. Tetrahedron Lett. 2005;46:4777–4779. doi: 10.1016/j.tetlet.2005.05.041
  • Schmitt JD. Annual reports in medicinal chemistry. Vol. 35. Bencherif M, editor. New York: Academic Press; 2000.
  • Kolb HC, Finn MG, Sharpless KB. Click chemistry: diverse chemical function from a few good reactions. Angew Chem Int Ed. 2001;40:2004–2021. doi:10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5
  • Yu S, Zhang G, Zhang W, et al. Synthesis and biological activities of a 3’-azido analogue of doxorubicin against drug-resistant cancer cells. J Med Chem. 2006;49:932–941. doi:10.3390/ijms13033671 doi: 10.1021/jm050800q
  • Guerrant W, Patil V, Canzoneri JC, et al. Dual targeting of histone deacetylase and topoisomerase II with novel bifunctional inhibitors. J Med Chem. 2012;55:1465–1477. doi: 10.1021/jm200799p
  • Singh MS, Chowdhury S, Koley S. Progress in 1, 3-dipolar cycloadditions in the recent decade: an update to strategic development towards the arsenal of organic synthesis. Tetrahedron. 2016;72:5257–5283. doi:10.1016/j.tet.2016.02.031 doi: 10.1016/j.tet.2016.07.044
  • Agalave SG, Maujan SR, Pore VS. Click chemistry: 1,2,3-triazoles as pharmacophores. Chem Asian J. 2011;6:2696–2718. doi: 10.1002/asia.201100432
  • Lin T-C, Cheng M-C, Peng SM, et al. Reactivity of iminophosphoranes. Formation of the piperazine ring. J Chin Chem Soc. 1995;42:543–546. doi: 10.1002/jccs.199500071
  • Sheldrick GM. A short history of SHELX. Acta Cryst A. 2008;64:112–122. doi: 10.1107/S0108767307043930

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.